Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$560M |
| 2 |
Apple
AAPL
|
+$375M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$354M |
| 4 |
Alibaba
BABA
|
+$275M |
| 5 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.83B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$703M |
| 3 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$677M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$297M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$291M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.78% |
| 2 | Financials | 5.08% |
| 3 | Healthcare | 4.24% |
| 4 | Consumer Discretionary | 4.16% |
| 5 | Energy | 3.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4026
PUT
Gold Fields
GFI
$29B
| $524K | ﹤0.01% |
148,900
-6,400
| -4% | -$18.9K |
|
4027
Saic
SAIC
$4.95B
| $524K | ﹤0.01% |
8,239
+2,884
| +54% | +$201K |
|
|
CBPO
4028
CALL
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $524K | ﹤0.01% |
+6,900
| New | +$508K |
|
4029
Atlantic Union Bankshares
AUB
$6.02B
| $523K | ﹤0.01% |
18,541
+12,403
| +202% | +$418K |
|
4030
Bank OZK
OZK
$5.6B
| $523K | ﹤0.01% |
22,915
+4,506
| +24% | +$125K |
|
4031
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.3B
| $523K | ﹤0.01% |
12,420
-5,700
| -31% | -$348K |
|
|
NPKI
4032
NPK International
NPKI
$1.06B
| $523K | ﹤0.01% |
76,092
+20,011
| +36% | +$163K |
|
4033
Advanced Energy
AEIS
$11.6B
| $521K | ﹤0.01% |
12,141
-16,525
| -58% | -$736K |
|
4034
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.1B
| $521K | ﹤0.01% |
19,767
-170
| -0.9% | -$5.01K |
|
|
GBT
4035
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $521K | ﹤0.01% |
12,700
-100
| -0.8% | -$3.75K |
|
|
BNY
4036
DELISTED
BlackRock New York Municipal Income Trust
BNY
| $520K | ﹤0.01% |
42,490
| – | – |
|
4037
Methode Electronics
MEI
$496M
| $520K | ﹤0.01% |
22,353
-1,024
| -4% | -$28.9K |
|
4038
CALL
Corpay
CPAY
$25B
| $520K | ﹤0.01% |
2,800
+700
| +33% | +$137K |
|
4039
SFL Corp
SFL
$1.64B
| $519K | ﹤0.01% |
49,191
+2,014
| +4% | +$25.2K |
|
4040
Interactive Brokers
IBKR
$39.2B
| $518K | ﹤0.01% |
37,856
-24,040
| -39% | -$321K |
|
4041
Towne Bank
TOWN
$3.46B
| $518K | ﹤0.01% |
21,635
+3,081
| +17% | +$84.6K |
|
4042
CALL
Acuity Brands
AYI
$9.83B
| $517K | ﹤0.01% |
4,500
+2,900
| +181% | +$358K |
|
|
WCC
4043
WESCO International
WCC
$16.7B
| $517K | ﹤0.01% |
10,767
+2,580
| +32% | +$134K |
|
4044
CarGurus
CARG
$3.27B
| $516K | ﹤0.01% |
15,286
-4,244
| -22% | -$170K |
|
4045
New Jersey Resources
NJR
$5.84B
| $516K | ﹤0.01% |
11,307
+8,381
| +286% | +$395K |
|
4046
Invesco Dorsey Wright Momentum ETF
PDP
$1.46B
| $516K | ﹤0.01% |
10,642
-2,350,295
| -100% | -$123M |
|
4047
OraSure Technologies
OSUR
$279M
| $514K | ﹤0.01% |
43,985
-18,066
| -29% | -$240K |
|
4048
Cohen & Steers
CNS
$4.23B
| $513K | ﹤0.01% |
14,950
+6,703
| +81% | +$248K |
|
4049
NovoCure
NVCR
$1.73B
| $513K | ﹤0.01% |
15,329
+7,045
| +85% | +$258K |
|
4050
CALL
Edgewell Personal Care
EPC
$1.25B
| $512K | ﹤0.01% |
13,700
+3,300
| +32% | +$144K |
|
Similar funds
Citigroup's Q4 2018 Portfolio in Review
As of Q4 2018, Citigroup held 8,079 positions worth $98.7B, down 12% from $112B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Citigroup deployed $3.55B of net new capital in Q4 2018, opening 273 new positions and adding to 3,486 existing holdings. Its largest new stake was Takeda Pharmaceutical: 6,548,306 shares worth $113M.
By sector, the portfolio is most concentrated in Technology at 5.8% of assets, up from 5.1% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.83B trimmed.
- Citigroup's largest Q4 2018 buy was Takeda Pharmaceutical: 6,548,306 shares worth $113M.
- Citigroup added most to Energy Transfer Partners in Q4 2018, an estimated $560M increase.
- Citigroup's biggest Q4 2018 reduction was iShares Russell 2000 ETF, cutting an estimated $1.83B.
- Citigroup fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $677M.
- Citigroup's ten largest holdings make up 17% of its $98.7B portfolio in Q4 2018.
- Citigroup opened 273 new positions and closed 357 in Q4 2018.
- Citigroup's portfolio value fell 12% quarter-over-quarter to $98.7B.
Based on Citigroup's 13F filing for Q4 2018, filed 12 Feb 2019.